Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery

NCT00243009 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Due to a lack of a referal base, study was terminated.

Conditions

Kidney Cancer

Interventions

DRUG: cyclosporine
DRUG: fludarabine phosphate
DRUG: mycophenolate mofetil
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: radiation therapy

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]